These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 33154723)
1. Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis. Ren L; Xu W; Overton JL; Yu S; Chiamvimonvat N; Thai PN Front Pharmacol; 2020; 11():562777. PubMed ID: 33154723 [TBL] [Abstract][Full Text] [Related]
2. Assessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis. Ren L; Xu W; Overton JL; Yu S; Chiamvimonvat N; Thai PN medRxiv; 2020 May; ():. PubMed ID: 32511539 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials. Eze P; Mezue KN; Nduka CU; Obianyo I; Egbuche O Am J Cardiovasc Dis; 2021; 11(1):93-107. PubMed ID: 33815925 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial. Schilling WHK; Mukaka M; Callery JJ; Llewelyn MJ; Cruz CV; Dhorda M; Ngernseng T; Waithira N; Ekkapongpisit M; Watson JA; Chandna A; Nelwan EJ; Hamers RL; Etyang A; Beg MA; Sow S; Yavo W; Allabi AC; Basnyat B; Sharma SK; Amofa-Sekyi M; Yonga P; Adler A; Yuentrakul P; Cope T; Thaipadungpanit J; Rienpradub P; Imwong M; Abdad MY; Blacksell SD; Tarning J; Goudjo FF; Dossou AD; Konaté-Touré A; Assi SB; Ouffoué K; Nasronudin N; Rachman BE; Romadhon PZ; Dewanto DD; Heryana MO; Novi T; Pasaribu AP; Mutiara M; Nasution MPR; Khairunnisa K; Dalimunthe FA; Airlangga E; Fahrezzy A; Subronto Y; Ananda NR; Rahardjani M; Rimainar A; Lucinde RK; Timbwa M; Onyango OE; Agutu C; Akech S; Hamaluba M; Kipyego J; Ngachi O; Haidara FC; Traoré OY; Diarra F; Khanal B; Dahal P; Shrestha S; Rijal S; Kabore Y; Adehossi E; Guindo O; Qamar FN; Kazi AM; Woodrow CJ; Laird S; Cheeba M; Ayles H; Cheah PY; Taylor WRJ; Batty EM; Chotivanich K; Pukrittayakamee S; Phumratanaprapin W; von Seidlein L; Dondorp A; Day NPJ; White NJ; PLoS Med; 2024 Sep; 21(9):e1004428. PubMed ID: 39264960 [TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions. Souza Botelho M; Bolfi F; Leite RGOF; Leite MSF; Banzato LR; Soares LT; Olivatti TOF; Mangolim AS; Oliveira FRK; Abbade LPF; Abbade JF; de Barros Almeida RAM; Simões Corrêa Galendi J; Thabane L; Dos Santos Nunes-Nogueira V Syst Rev; 2021 Nov; 10(1):294. PubMed ID: 34736537 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine. de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793 [TBL] [Abstract][Full Text] [Related]
8. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis. Liu D; Li X; Zhang Y; Kwong JS; Li L; Zhang Y; Xu C; Li Q; Sun X; Tian H; Li S Drug Des Devel Ther; 2018; 12():1685-1695. PubMed ID: 29928112 [TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19. Mittal N; Mittal R; Gupta MC; Kaushal J; Chugh A; Khera D; Singh S J Family Med Prim Care; 2021 Jun; 10(6):2126-2139. PubMed ID: 34322403 [TBL] [Abstract][Full Text] [Related]
10. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis. Elavarasi A; Prasad M; Seth T; Sahoo RK; Madan K; Nischal N; Soneja M; Sharma A; Maulik SK; Shalimar ; Garg P J Gen Intern Med; 2020 Nov; 35(11):3308-3314. PubMed ID: 32885373 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis. Kumar J; Jain S; Meena J; Yadav A J Infect Chemother; 2021 Jun; 27(6):882-889. PubMed ID: 33678548 [TBL] [Abstract][Full Text] [Related]
12. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19). Shah S; Das S; Jain A; Misra DP; Negi VS Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213 [TBL] [Abstract][Full Text] [Related]
13. An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy. Celotto S; Veronese N; Barbagallo M; Ometto F; Smith L; Pardhan S; Barnett Y; Ilie PC; Soysal P; Lagolio E; Kurotschka PK; Tonelli R; Demurtas J Int J Infect Dis; 2021 Feb; 103():599-606. PubMed ID: 33316389 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials. Martins-Filho PR; Ferreira LC; Heimfarth L; Araújo AAS; Quintans-Júnior LJ Lancet Reg Health Am; 2021 Oct; 2():100062. PubMed ID: 34485970 [TBL] [Abstract][Full Text] [Related]
15. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19. Ho TC; Wang YH; Chen YL; Tsai WC; Lee CH; Chuang KP; Chen YA; Yuan CH; Ho SY; Yang MH; Tyan YC Pathogens; 2021 Feb; 10(2):. PubMed ID: 33671315 [TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment. Ghazy RM; Almaghraby A; Shaaban R; Kamal A; Beshir H; Moursi A; Ramadan A; Taha SHN Sci Rep; 2020 Dec; 10(1):22139. PubMed ID: 33335141 [TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis. Di Stefano L; Ogburn EL; Ram M; Scharfstein DO; Li T; Khanal P; Baksh SN; McBee N; Gruber J; Gildea MR; Clark MR; Goldenberg NA; Bennani Y; Brown SM; Buckel WR; Clement ME; Mulligan MJ; O'Halloran JA; Rauseo AM; Self WH; Semler MW; Seto T; Stout JE; Ulrich RJ; Victory J; Bierer BE; Hanley DF; Freilich D; PLoS One; 2022; 17(9):e0273526. PubMed ID: 36173983 [TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials. Ebina-Shibuya R; Namkoong H; Horita N; Kato H; Hara Y; Kobayashi N; Kaneko T J Thorac Dis; 2021 Jan; 13(1):202-212. PubMed ID: 33569200 [TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial. Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933 [TBL] [Abstract][Full Text] [Related]
20. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story. Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]